Literature DB >> 30110707

Prepubertal Children Exposed to Maternal Gestational Diabetes Have Latent Low-Grade Inflammation.

Leena Antikainen1,2, Jarmo Jääskeläinen1,2, Henrikki Nordman1,2, Raimo Voutilainen1,2, Hanna Huopio2.   

Abstract

BACKGROUND: Maternal gestational diabetes mellitus (GDM) and overweight are associated with an increased risk of obesity and the metabolic syndrome in the adult offspring. We studied the influence of maternal GDM on prepubertal children's height, weight, body mass index (BMI), lipid and glucose metabolism, and low-grade inflammation.
METHODS: A cohort of 135 prepubertal Caucasian children (age range 4.4-9.7 years) was studied in a controlled cross-sectional study. Seventy-seven children had been exposed to maternal GDM, and 58 children born after a normal pregnancy served as controls. The outcomes were height, weight, BMI, blood pressure, and biochemical markers of glucose and lipid metabolism and inflammation.
RESULTS: There were no differences in height, weight, BMI, fasting serum insulin, plasma glucose, lipids, or blood pressure between the study groups. However, high-sensitivity C-reactive protein (hs-CRP) was significantly higher in the GDM group than in the controls (p = 0.001).
CONCLUSIONS: Higher hs-CRP as a marker of low-grade inflammation was detected in prepubertal children exposed to maternal GDM, but no differences were seen in height, weight, BMI, or markers of glucose and lipid metabolism compared to control children. This finding may reflect an ongoing process of metabolic changes in children born after a GDM pregnancy.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Child; Gestational diabetes; Growth; Inflammation; Metabolism

Mesh:

Year:  2018        PMID: 30110707     DOI: 10.1159/000491938

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  2 in total

1.  Maternal Glycemia During Pregnancy and Child Carotid Intima Media Thickness, Pulse Wave Velocity, and Augmentation Index.

Authors:  Wen Lun Yuan; Jinjie Lin; Michael S Kramer; Keith M Godfrey; Peter D Gluckman; Yap-Seng Chong; Lynette P Shek; Kok Hian Tan; Shiao-Yng Chan; Johan G Eriksson; Fabian Yap; Yung Seng Lee; Jonathan T L Choo; Lieng Hsi Ling
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 6.134

2.  LncRNA XIST serves as a diagnostic biomarker in gestational diabetes mellitus and its regulatory effect on trophoblast cell via miR-497-5p/FOXO1 axis.

Authors:  Yanchuan Li; Xiaohua Yuan; Ziyun Shi; Haili Wang; Duomei Ren; Ya Zhang; Yangyang Fan; Yanfeng Liu; Zhangxia Cui
Journal:  Cardiovasc Diagn Ther       Date:  2021-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.